Thoracic Surgery & Oncology Tumor Board

MGR26032

In the United States, lung cancer continues to be the leading cause of cancer-related fatalities, accounting for 11.7% of all cancer cases. It is alarming that approximately 226,650 Americans are projected to receive a lung cancer diagnosis in 2025 alone, resulting in the loss of 124,730 lives. (Source: Cancer Facts & Figures, American Cancer Society 2025)

At UCSF Helen Diller Family Comprehensive Cancer Center, our Interim Chief, Thoracic Surgery, Dr. Johannes Kratz, leads the Thoracic Surgery & Oncology Tumor Board. This program holds accreditation from the ACCME and aims to educate practicing physicians and nurses specializing in thoracic oncology, pulmonology, radiation oncology, pathology, and surgery. Its objective is to promote evidence-based best practices for the management of patients with lung malignancies. By following these guidelines, our goal is to extend disease-free progression, enhance overall survival rates, and improve the quality of life for our patients.

This program is specifically designed for practicing physicians and nurses at UCSF who specialize in thoracic oncology, pulmonology, radiation oncology, pathology, and surgery.

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF designates this activity for a maximum of 50 AMA PRA Category 1 Credit(s)TM*.

Physicians should claim credit commensurate with their participation in the activity during AY 25-26

Tutorial Videos for Learners
How to Access the CE Portal?
How to Create a New Account?
How to Login into the CE portal?
How a Learner can view and claim the CE credit?